Search - tctmd.com

Displaying 501 - 520 of 3077

Sort: Relevancy | Date

News Daily News

FDA: No Cardiovascular Event Reduction Claim for Ezetimibe

Shelley Wood

February 16, 2016

News Daily News

SORT OUT IV al cabo de 5 Años: Se Confirma una Mejor Seguridad a Largo Plazo para los Stents de 2ª Generación

L.A. McKeown

February 16, 2016

News Daily News

El Riego que Añaden los Cuadros de Shock a los IAM se Limita al los Primeros Meses Post- Alta Hospitalaria

Caitlin E. Cox

February 16, 2016

News Daily News

研究认为有数据支持针对患者风险而非 LDL 胆固醇目标进行治疗

Michael O'Riordan

February 15, 2016

News Daily News

Según un Informe los Datos Avalan Tratar el Riesgo de los Pacientes No las Dianas de Colesterol LBD

Michael O'Riordan

February 15, 2016

News Daily News

Data Support Treating Patient Risk, Not LDL Cholesterol Targets, Paper Argues

Michael O'Riordan

February 15, 2016

News Daily News

La Cardio-Oncología Ofrece a los Médicos la Oportunidad de Adentrarse en el ‘Salvaje Oeste’

L.A. McKeown

February 15, 2016

Presentation JIM 2016

Optimal Duration of Oral Antiplatelet Therapy

Presenter: Dominick J. Angiolillo

February 11, 2016

Presentation JIM 2016

Medical therapy optimization with new anti-ischemic drugs

Presenter: Giuseppe Musumeci

February 11, 2016

Presentation JIM 2016

GP2b3a blockers:Back to the future

Presenter: Arnoud van ?t Hof

February 11, 2016

Presentation JIM 2016

Clinical Case: High risk ACS

Presenter: Giuseppe Tarantini

February 11, 2016

Presentation JIM 2016

The COMBO dual therapy stent: From the REMEDEE registry to the REDUCE trial

Presenter: Giuseppe De Luca

February 10, 2016

Presentation JIM 2016

DES safety and DAPT: The Ultimaster DES

Presenter: Corrado Tamburino

February 10, 2016

Presentation JIM 2016

BioFreedom DCS With 1-Month DAPT: The New Standard For High Bleeding Risk Patients

Presenter: Antonio L. Bartorelli

February 10, 2016

Presentation

Ticagrelor vs Clopidogrel in Troponin-Negative Patients With Low-Risk ACS Undergoing Ad Hoc PCI

Presenter: Dominick J. Angiolillo

February 09, 2016

News Daily News

Ticagrelor Loading Dose Provides Faster Platelet Inhibition Than Clopidogrel in Ad Hoc PCI

L.A. McKeown

February 09, 2016

News Daily News

他汀类药物可能会保护无症状 PAD 患者免于死亡、心血管事件

Caitlin E. Cox

February 08, 2016

Presentation

Why are the data for Pretreatment Weak?

Presenter: Duane S. Pinto

February 08, 2016

Presentation

Timing of Clopidogrel Loading in US Practice

Presenter: Gregg W. Stone

February 08, 2016

News Daily News

Statins Possibly Protect Against Death, CV Events in Asymptomatic PAD PatientsLas Estatinas Podrían Proteger frente a la Muerte y los Episodios CV en Pacientes EAP Asintomáticos

Caitlin E. Cox

February 08, 2016

Advertisement

FDA: No Cardiovascular Event Reduction Claim for Ezetimibe

SORT OUT IV al cabo de 5 Años: Se Confirma una Mejor Seguridad a Largo Plazo para los Stents de 2ª Generación

El Riego que Añaden los Cuadros de Shock a los IAM se Limita al los Primeros Meses Post- Alta Hospitalaria

研究认为有数据支持针对患者风险而非 LDL 胆固醇目标进行治疗

Según un Informe los Datos Avalan Tratar el Riesgo de los Pacientes No las Dianas de Colesterol LBD

Data Support Treating Patient Risk, Not LDL Cholesterol Targets, Paper Argues

La Cardio-Oncología Ofrece a los Médicos la Oportunidad de Adentrarse en el ‘Salvaje Oeste’

Optimal Duration of Oral Antiplatelet Therapy

Medical therapy optimization with new anti-ischemic drugs

GP2b3a blockers:Back to the future

Clinical Case: High risk ACS

The COMBO dual therapy stent: From the REMEDEE registry to the REDUCE trial

DES safety and DAPT: The Ultimaster DES

BioFreedom DCS With 1-Month DAPT: The New Standard For High Bleeding Risk Patients

Ticagrelor vs Clopidogrel in Troponin-Negative Patients With Low-Risk ACS Undergoing Ad Hoc PCI

Ticagrelor Loading Dose Provides Faster Platelet Inhibition Than Clopidogrel in Ad Hoc PCI

他汀类药物可能会保护无症状 PAD 患者免于死亡、心血管事件

Why are the data for Pretreatment Weak?

Timing of Clopidogrel Loading in US Practice

Statins Possibly Protect Against Death, CV Events in Asymptomatic PAD PatientsLas Estatinas Podrían Proteger frente a la Muerte y los Episodios CV en Pacientes EAP Asintomáticos

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content